Agency Information Collection Activities: Proposed Collection; Comment Request, 7776-7778 [2020-02671]

Download as PDF 7776 Federal Register / Vol. 85, No. 28 / Tuesday, February 11, 2020 / Notices Dated: February 5, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings khammond on DSKJM1Z7X2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group; Diabetes, Endocrinology and Metabolic Diseases B Subcommittee DDK–B Subcommittee. Date: March 11–13, 2020. Time: 5:30 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, Conference Room Rooftop, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Charlene J. Repique, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7347, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7791, charlene.repique@nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group; Digestive Diseases and Nutrition C Subcommittee DDK–C Subcommittee. Date: March 12–13, 2020. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, Conference Room Embassy/Potomac, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Maria E. Davila-Bloom, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Activities, NIDDK, National Institutes of Health, Room 7017, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7637, davilabloomm@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) VerDate Sep<11>2014 18:19 Feb 10, 2020 Jkt 250001 [FR Doc. 2020–02635 Filed 2–10–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Nutrition Obesity Research Centers (P30). Date: March 9–10, 2020. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, Conference Room Embassy/Potomac, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Thomas A. Tatham, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Activities, NIDDK, National Institutes of Health, Room 7021, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–3993, tathamt@ mail.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Integrating Large Scale Genomics and Functional Studies to Accelerate FSGS/NS Discovery. Date: March 11, 2020. Time: 12:00 p.m. to 1:15 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Paul A. Rushing, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–8895, rushingp@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 Special Emphasis Panel; Application of Progenitor Niche Signals to Ex Vivo Nephrogenesis. Date: March 12, 2020. Time: 3:00 p.m. to 4:15 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Paul A. Rushing, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–8895, rushingp@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: February 5, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–02639 Filed 2–10–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection; Comment Request In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning the opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer at (240) 276– 0361. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use E:\FR\FM\11FEN1.SGM 11FEN1 7777 Federal Register / Vol. 85, No. 28 / Tuesday, February 11, 2020 / Notices of automated collection techniques or other forms of information technology. Proposed Project: Mandatory Guidelines for Federal Workplace Drug Testing Programs (OMB No. 0930– 0158)—Revision SAMHSA will request OMB approval for a revision of the Federal Drug Testing Custody and Control Form (CCF) for federal agency and federally regulated drug testing programs which must comply with the HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine (UrMG) dated January 23, 2017 (82 FR 7920) and using Oral Fluid (OFMG) dated October 25, 2019, and OMB approval for information provided by test facilities (laboratories and Instrumented Initial Test Facilities, IITFs) for the National Laboratory Certification Program (NLCP). The CCF is used by all federal agencies and employers regulated by the Department of Transportation (DOT) and the Nuclear Regulatory Commission (NRC) to document the collection and chain of custody of urine specimens at the collection site, for HHS-certified test facilities to report results, and for Medical Review Officers (MROs) to document and report a verified result. SAMHSA allows the use of the CCF as a paper or electronic form. The current OMB-approved CCF has an August 31, 2020 expiration date. SAMHSA has resubmitted the CCF with major content revisions to the form for OMB approval. These revisions are: Copies 1–5 Revised Step 1 1. Added ‘‘Collector Contact Info:’’ and ‘‘Other’’ line (e.g., email) Revised Step 2 1. Put Urine and Oral Fluid checkboxes above Step 2 for collector to annotate 2. Expanded to 4 lines for collector entries: —General entry for Split, Single, or None Provided (same as current) —Entries specific to urine collection (moved ‘‘Collector reads urine temperature within 4 minutes’’ here; other entries same as current) —Entries specific to oral fluid collection: added ‘‘Split Type’’ with checkboxes for Serial, Concurrent, and Subdivided; ‘‘Each Device Within Expiration Date?’’ with checkboxes Yes or No; and Volume Indicator(s) Observed checkbox) —Remarks (same as current) Revised Step 3 1. Edited instruction to state ‘‘collector affixes seal(s) to bottle(s)/tube(s)’’ Revised Step 4 (Collector Section) 1. Edited ‘‘Specimen Bottle(s) Released To’’ box to state ‘‘Specimen Bottle(s)/Tubes(s) Released To’’ Copy 1 (Test Facility Copy) Revised Step 4 (Accessioner Section) 1. Edited ‘‘Specimen Bottle(s) Released To’’ box to state ‘‘Specimen Bottle(s)/Tubes(s) Released To’’ 2. Added ‘‘Primary/Single Specimen Device Expiration Date’’ and ‘‘Split Specimen Device Expiration Date’’ fields for accessioner to annotate expiration dates of oral fluid collection devices Revised Step 5a (Certification and Reporting Section) 1. Removed analyte names and checkboxes 2. Repositioned results and checkboxes: Moved REJECTED FOR TESTING, ADULTERATED, SUBSTITUTED and INVALID RESULT checkboxes; moved POSITIVE checkbox to be under DILUTE 3. Added line for certifying scientist to record positive analytes and concentrations, and added ‘‘Analyte(s) in ng/mL’’ instruction (aligned under ‘‘POSITIVE for:’’) Copy 2 (Medical Review Officer Copy) Revised Step 6 (Donor Section) 1. Edited donor certification statement to state ‘‘specimen bottle/tubes’’ Revised Step 7 (MRO Section—Primary Specimen) 1. Put Urine and Oral Fluid checkboxes above Step 6 for MRO to annotate khammond on DSKJM1Z7X2PROD with NOTICES Custody and Control Form: 1 Donor ............................................................................ Collector ........................................................................ Laboratory ..................................................................... IITF ................................................................................ Medical Review Officer ................................................. NLCP Application Form: 2 Laboratory ..................................................................... VerDate Sep<11>2014 18:19 Feb 10, 2020 Jkt 250001 Responses per respondent Number of respondents Form/respondent PO 00000 Frm 00065 Bottom of Copies Revised Copy 1 1. Edited label/seal at bottom of Copy 1 to allow for modification (e.g., perforations, label with transparent seal on one side, and separate label and seal) Revised Copies 3–5 1. Removed Steps 6 and 7 (MRO sections) 2. Moved Public Burden Statement from the back to the front of the copies Additional Edits to Copy 5 1. Moved Privacy Act Statement (for federal employees) from the back to the front of the copy 2. Removed Instructions for Completing the CCF from the back. SAMHSA will post instructions for completing the Federal CCF for urine and oral fluid on their website. Based upon information from federal agencies and from DOT concerning their regulated industries, the number of respondents has increased from 5.4 million to 6.7 million, which increases the total burden hours by 170,701.8. Laboratories and IITFs seeking HHS certification under the NLCP must complete and submit the NLCP application form. The NLCP application form has not been revised compared to the previous form. Prior to an inspection, an HHScertified laboratory or IITF is required to submit specific information regarding its procedures. Collecting this information prior to an inspection allows the inspectors to thoroughly review and understand the testing procedures before arriving for the onsite inspection. The NLCP information checklist has not been revised compared to the previous form. The annual total burden estimates for the CCF, the NLCP application, the NLCP information checklist, and the NLCP recordkeeping requirements are shown in the following table. Total number of responses Burden per response (hours) Annual burden (hours) 6,726,610 6,726,610 6,726,610 1 6,726,610 1 1 1 0 1 6,726,610 6,726,610 6,726,610 0 6,726,610 0.08 0.07 0.05 0.05 0.05 538,128.8 378,000 336,330 0 270,000 5 5 5 3 15 Fmt 4703 Sfmt 4703 E:\FR\FM\11FEN1.SGM 11FEN1 7778 Federal Register / Vol. 85, No. 28 / Tuesday, February 11, 2020 / Notices IITF ................................................................................ Sections B and C—NLCP Inspection Checklist: Laboratory ..................................................................... IITF ................................................................................ Record Keeping: Laboratory ..................................................................... IITF ................................................................................ Total ....................................................................... Send comments to Carlos Graham, SAMHSA Reports Clearance Officer, Room 15–E–57–A, 5600 Fishers Lane, Rockville, MD 20857 OR email a copy to Carlos.Graham@samhsa.hhs.gov. Written comments should be received by April 13, 2020. Jennifer Wilson, Budget Analyst. [FR Doc. 2020–02671 Filed 2–10–20; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Docket ID FEMA–2020–0007; OMB No. 1660–0143] Agency Information Collection Activities: Proposed Collection; Comment Request; Federal Emergency Management Agency Individual Assistance Customer Satisfaction Surveys Federal Emergency Management Agency, DHS. ACTION: Notice and request for comments. AGENCY: The Federal Emergency Management Agency, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take the opportunity to comment on a revision of a currently approved information collection. In accordance with the Paperwork Reduction Act of 1995, this notice seeks comments concerning the collection of Individual Assistance customer satisfaction survey responses and information for assessment and improvement of the delivery of disaster assistance to individuals and households. DATES: Comments must be submitted on or before April 13, 2020. ADDRESSES: To avoid duplicate submissions to the docket, please use khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:19 Feb 10, 2020 Jkt 250001 Responses per respondent Number of respondents Form/respondent Total number of responses Frm 00066 Annual burden (hours) 0 0 0 3 0 29 0 1 0 29 0 1 1 29 0 29 0 1 0 29 0 250 250 7,250 0 6,726,673 ........................ 26,906,503 ........................ 1,529,753 only one of the following means to submit comments: (1) Online. Submit comments at www.regulations.gov under Docket ID FEMA–2020–0007. Follow the instructions for submitting comments. (2) Mail. Submit written comments to Docket Manager, Office of Chief Counsel, DHS/FEMA, 500 C Street SW, Room 8NE, Washington, DC 20472– 3100. All submissions received must include the agency name and Docket ID. Regardless of the method used for submitting comments or material, all submissions will be posted, without change, to the Federal eRulemaking Portal at http://www.regulations.gov, and will include any personal information you provide. Therefore, submitting this information makes it public. You may wish to read the Privacy and Security Notice that is available via the link on the homepage of www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Jessica Guillory, Statistician, Customer Survey & Analysis Section, Recovery Directorate, FEMA at Jessica.Guillory@ fema.dhs.gov. You may contact the Records Management Division for copies of the proposed collection of information at email address: FEMAInformation-Collections-Management@ fema.dhs.gov. SUPPLEMENTARY INFORMATION: This collection is in accordance with Executive Orders 12862 and 13571 requiring all Federal agencies to survey customers to determine the kind and quality of services they want and their level of satisfaction with existing services. The Government Performance and Results Act (GPRA) requires agencies to set missions and goals and measure performance against them and the GPRA Modernization Act of 2010 requires quarterly performance assessments of government programs for the purposes of assessing agency performance and improvement. FEMA will fulfill these requirements by collecting customer satisfaction program information through surveys of the PO 00000 Burden per response (hours) Fmt 4703 Sfmt 4703 Recovery Directorate’s external customers. Collection of Information Title: Federal Emergency Management Agency Individual Assistance Customer Satisfaction Surveys. Type of Information Collection: Revision of a currently approved information collection. OMB Number: 1660–0143. FEMA Forms: FEMA Form 519–0–36, Initial Survey—Phone, FEMA Form 519–0–37, Initial Survey—Electronic; FEMA Form 519–0–38, Contact Survey—Phone, FEMA Form 519–0–39, Contact Survey—Electronic; FEMA Form 519–0–40, Assessment Survey— Phone, FEMA Form 519–0–41, Assessment Survey—Electronic. Abstract: Federal agencies are required to survey their customers to determine the kind and quality of services customers want and their level of satisfaction with those services. Analysis from the survey is used to measure FEMA’s Strategic Plan’s objective 3.1 Streamline the Disaster Survivor Experience. Affected Public: Individuals or households. Estimated Number of Respondents: 38,864. Estimated Number of Responses: 38,864. Estimated Total Annual Burden Hours: 8,982. Estimated Total Annual Respondent Cost: $327,573 Estimated Respondents’ Operation and Maintenance Costs: $0. Estimated Respondents’ Capital and Start-Up Costs: $0. Estimated Total Annual Cost to the Federal Government: $1,785,889. Comments Comments may be submitted as indicated in the ADDRESSES caption above. Comments are solicited to (a) evaluate whether the proposed data collection is necessary for the proper performance of the agency, including whether the information shall have practical utility; (b) evaluate the E:\FR\FM\11FEN1.SGM 11FEN1

Agencies

[Federal Register Volume 85, Number 28 (Tuesday, February 11, 2020)]
[Notices]
[Pages 7776-7778]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02671]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Proposed Collection; 
Comment Request

    In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction 
Act of 1995 concerning the opportunity for public comment on proposed 
collections of information, the Substance Abuse and Mental Health 
Services Administration (SAMHSA) will publish periodic summaries of 
proposed projects. To request more information on the proposed projects 
or to obtain a copy of the information collection plans, call the 
SAMHSA Reports Clearance Officer at (240) 276-0361.
    Comments are invited on: (a) Whether the proposed collections of 
information are necessary for the proper performance of the functions 
of the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use

[[Page 7777]]

of automated collection techniques or other forms of information 
technology.

Proposed Project: Mandatory Guidelines for Federal Workplace Drug 
Testing Programs (OMB No. 0930-0158)--Revision

    SAMHSA will request OMB approval for a revision of the Federal Drug 
Testing Custody and Control Form (CCF) for federal agency and federally 
regulated drug testing programs which must comply with the HHS 
Mandatory Guidelines for Federal Workplace Drug Testing Programs using 
Urine (UrMG) dated January 23, 2017 (82 FR 7920) and using Oral Fluid 
(OFMG) dated October 25, 2019, and OMB approval for information 
provided by test facilities (laboratories and Instrumented Initial Test 
Facilities, IITFs) for the National Laboratory Certification Program 
(NLCP).
    The CCF is used by all federal agencies and employers regulated by 
the Department of Transportation (DOT) and the Nuclear Regulatory 
Commission (NRC) to document the collection and chain of custody of 
urine specimens at the collection site, for HHS-certified test 
facilities to report results, and for Medical Review Officers (MROs) to 
document and report a verified result. SAMHSA allows the use of the CCF 
as a paper or electronic form.
    The current OMB-approved CCF has an August 31, 2020 expiration 
date. SAMHSA has resubmitted the CCF with major content revisions to 
the form for OMB approval. These revisions are:

Copies 1-5

Revised Step 1
1. Added ``Collector Contact Info:'' and ``Other'' line (e.g., email)
Revised Step 2
1. Put Urine and Oral Fluid checkboxes above Step 2 for collector to 
annotate
2. Expanded to 4 lines for collector entries:
    --General entry for Split, Single, or None Provided (same as 
current)
    --Entries specific to urine collection (moved ``Collector reads 
urine temperature within 4 minutes'' here; other entries same as 
current)
    --Entries specific to oral fluid collection: added ``Split Type'' 
with checkboxes for Serial, Concurrent, and Subdivided; ``Each Device 
Within Expiration Date?'' with checkboxes Yes or No; and Volume 
Indicator(s) Observed checkbox)
    --Remarks (same as current)
Revised Step 3
1. Edited instruction to state ``collector affixes seal(s) to 
bottle(s)/tube(s)''
Revised Step 4 (Collector Section)
1. Edited ``Specimen Bottle(s) Released To'' box to state ``Specimen 
Bottle(s)/Tubes(s) Released To''

Copy 1 (Test Facility Copy)

Revised Step 4 (Accessioner Section)
1. Edited ``Specimen Bottle(s) Released To'' box to state ``Specimen 
Bottle(s)/Tubes(s) Released To''
2. Added ``Primary/Single Specimen Device Expiration Date'' and ``Split 
Specimen Device Expiration Date'' fields for accessioner to annotate 
expiration dates of oral fluid collection devices
Revised Step 5a (Certification and Reporting Section)
1. Removed analyte names and checkboxes
2. Repositioned results and checkboxes: Moved REJECTED FOR TESTING, 
ADULTERATED, SUBSTITUTED and INVALID RESULT checkboxes; moved POSITIVE 
checkbox to be under DILUTE
3. Added line for certifying scientist to record positive analytes and 
concentrations, and added ``Analyte(s) in ng/mL'' instruction (aligned 
under ``POSITIVE for:'')

Copy 2 (Medical Review Officer Copy)

Revised Step 6 (Donor Section)
1. Edited donor certification statement to state ``specimen bottle/
tubes''
Revised Step 7 (MRO Section--Primary Specimen)
1. Put Urine and Oral Fluid checkboxes above Step 6 for MRO to annotate

Bottom of Copies

Revised Copy 1
1. Edited label/seal at bottom of Copy 1 to allow for modification 
(e.g., perforations, label with transparent seal on one side, and 
separate label and seal)
Revised Copies 3-5
1. Removed Steps 6 and 7 (MRO sections)
2. Moved Public Burden Statement from the back to the front of the 
copies
Additional Edits to Copy 5
1. Moved Privacy Act Statement (for federal employees) from the back to 
the front of the copy
2. Removed Instructions for Completing the CCF from the back. SAMHSA 
will post instructions for completing the Federal CCF for urine and 
oral fluid on their website.
    Based upon information from federal agencies and from DOT 
concerning their regulated industries, the number of respondents has 
increased from 5.4 million to 6.7 million, which increases the total 
burden hours by 170,701.8.
    Laboratories and IITFs seeking HHS certification under the NLCP 
must complete and submit the NLCP application form. The NLCP 
application form has not been revised compared to the previous form.
    Prior to an inspection, an HHS-certified laboratory or IITF is 
required to submit specific information regarding its procedures. 
Collecting this information prior to an inspection allows the 
inspectors to thoroughly review and understand the testing procedures 
before arriving for the onsite inspection. The NLCP information 
checklist has not been revised compared to the previous form.
    The annual total burden estimates for the CCF, the NLCP 
application, the NLCP information checklist, and the NLCP recordkeeping 
requirements are shown in the following table.

----------------------------------------------------------------------------------------------------------------
                                                                                    Burden per
         Form/respondent             Number of     Responses per   Total number      response      Annual burden
                                    respondents     respondent     of responses       (hours)         (hours)
----------------------------------------------------------------------------------------------------------------
Custody and Control Form: \1\
    Donor.......................       6,726,610               1       6,726,610            0.08       538,128.8
    Collector...................       6,726,610               1       6,726,610            0.07         378,000
    Laboratory..................       6,726,610               1       6,726,610            0.05         336,330
    IITF........................               1               0               0            0.05               0
    Medical Review Officer......       6,726,610               1       6,726,610            0.05         270,000
NLCP Application Form: \2\
    Laboratory..................               5               5               5               3              15

[[Page 7778]]

 
    IITF........................               0               0               0               3               0
Sections B and C--NLCP
 Inspection Checklist:
    Laboratory..................              29               1              29               1              29
    IITF........................               0               0               0               1               0
Record Keeping:
    Laboratory..................              29               1              29             250           7,250
    IITF........................               0               0               0             250               0
                                 -------------------------------------------------------------------------------
        Total...................       6,726,673  ..............      26,906,503  ..............       1,529,753
----------------------------------------------------------------------------------------------------------------

    Send comments to Carlos Graham, SAMHSA Reports Clearance Officer, 
Room 15-E-57-A, 5600 Fishers Lane, Rockville, MD 20857 OR email a copy 
to [email protected]. Written comments should be received by 
April 13, 2020.

Jennifer Wilson,
Budget Analyst.
[FR Doc. 2020-02671 Filed 2-10-20; 8:45 am]
BILLING CODE 4162-20-P